Skip to content

Clinical trials

Myasthenia Gravis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Country / region: Italy Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20131
20141
20161
20182
20199
20202
20219
20224
20234
202416
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22
Completed21
Active, not recruiting11
Terminated6
Not yet recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx14
Alexion Pharmaceuticals, Inc.10
UCB Biopharma SRL9
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
Amgen2
Hoffmann-La Roche2
Immunovant Sciences GmbH2
Momenta Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2
Cartesian Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis64
Neuromyelitis Optica2
Thymoma2
Adrenal Insufficiency1
Anxiety Disorders1
Atypical Hemolytic Uremic Syndrome1
Autoimmune Diseases1
Autoimmune Diseases of the Nervous System1
Hemoglobinuria, Paroxysmal1
Isaacs Syndrome1

Trials

Showing 26 to 50 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.